therapy trial - Robuta Search

https://www.ynetnews.com/health_science/article/h1vzwjeowx Matricelf to launch first-in-human spinal cord therapy trial with Sheba Medical Cente Mar 24, 2026 - Israeli biotech Matricelf teams with Sheba to advance first human trial for spinal cord injury treatment using autologous implants launch first spinal cord therapy trial sheba medical human https://www.statnews.com/2025/12/15/gene-therapy-capsida-biotherapeutics-clinical-trial-death-ramifications/ Gene therapy trial death unnerves promising area of brain research | STAT Dec 16, 2025 - Researchers fear a broad risk for any virus genetically designed to penetrate the blood-brain barrier after no hint of issues prior to Capsida trial death. gene therapy trial brain research death promising area https://www.masseyeandear.org/news/press-releases/2024/06/gene-therapy-trial-shows-restored-hearing-and-speech-in-children-born-deaf New Gene Therapy Trial Shows Restored Hearing and Speech in Children Born Deaf, Treated in Both Ears Administering gene therapy in both ears of five children with DFNB9 led to additional benefits compared to previous trial, including sound source localization... gene therapy trial children born new shows restored https://www.biopharmadive.com/news/astellas-again-hits-pause-on-gene-therapy-trial/605928/ Astellas again hits pause on gene therapy trial | BioPharma Dive The company is holding off dosing more patients with AT132, a potential treatment for a deadly neuromuscular disease, after one recently experienced a serious... gene therapy trial hits pause biopharma dive astellas https://www.genethon.com/genethon-presents-two-year-consolidated-results-of-its-gene-therapy-trial-for-duchenne-muscular-dystrophy-maintenance-of-motor-functions-and-significant-sustained-reduction-in-cpk-levels-in-patients/ Genethon Presents Two Year Consolidated Results of Its Gene Therapy Trial for Duchenne Muscular... Jun 17, 2025 - Paris, France (May 17, 2025) – Genethon unveiled the 2-year follow-up data from its GNT0004 gene therapy clinical trial for Duchenne Muscular Dystrophy... gene therapy trial presents two duchenne muscular year consolidated https://atricure.com/healthcare-professionals/therapies/hybrid-af-therapy/clinical-data Hybrid AF Therapy Clinical Data | CONVERGE Trial Results hybrid af therapy clinical data trial results converge https://www.saltwire.com/nova-scotia/cole-harbour-family-chosen-for-groundbreaking-life-changing-treatment-for-daughters-rare-genetic-disorder Nova Scotia girl becomes third person in trial of promising gene replacement therapy for rare... nova scotia girl becomes third person replacement therapy trial https://humanprogress.org/first-therapy-chatbot-trial-yields-mental-health-benefits/?ref=topic&related=1907 First Therapy Chatbot Trial Yields Mental Health Benefits - Human Progress mental health benefits first therapy human progress chatbot trial https://news.cancerresearchuk.org/2026/03/09/reducing-side-effects-of-hormone-therapy-for-prostate-cancer-the-enhance-trial/ Reducing the side effects of hormone therapy for prostate cancer: the ENHANCE trial - Cancer... Mar 10, 2026 - We’re launching a £3.2 million clinical trial to help men with advanced prostate cancer by reducing the side effects of hormone therapy (HRT). side effects hormone therapy prostate cancer reducing enhance https://www.cambridge.org/core/journals/psychological-medicine/article/schema-therapy-for-violent-pd-offenders-a-randomized-clinical-trial/A6A8E0C8E512EFF14D50B98A798A3C71 Schema therapy for violent PD offenders: a randomized clinical trial | Psychological Medicine |... Schema therapy for violent PD offenders: a randomized clinical trial - Volume 53 Issue 1 randomized clinical trial schema therapy psychological medicine violent pd https://news.cuanschutz.edu/news-stories/from-lab-to-clinic-cu-anschutz-launches-phase-1-clinical-trial-of-promising-combination-therapy-for-resistant-ovarian-cancer From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy... Jan 29, 2026 - From lab to clinic: CU Anschutz launches phase 1 clinical trial of promising combination therapy for resistant ovarian cancer. phase 1 clinical cu anschutz combination therapy lab launches https://www.bnl.gov/newsroom/news.php?a=122504 Groundbreaking Cancer Therapy Clinical Trial with U.S. Department of Energy's Accelerator-Produced... Accelerator-produced Ac-225 to be used in an FDA-approved targeted cancer therapy clinical trial for the first time cancer therapy clinical trial energy accelerator groundbreaking department https://immunisbiomedical.com/stem-myo-program/phase-1-2a-clinical-trial/ Immunis completed a Phase 1/2a clinical trial for its multi-active therapy Jan 29, 2026 - . The trial tested the safety, tolerability and preliminary efficacy of IMM01-STEM in elderly individuals with muscle atrophy associated with knee... phase 1 clinical trial completed 2a multi https://www.mdanderson.org/cancerwise/car-nk-cell-therapy-clinical-trial-puts-follicular-lymphoma-survivor-into-remission.h00-159780390.html?referrer=philanthropic CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission | UT MD Anderson Oct 29, 2025 - Non-Hodgkin lymphoma survivor JC Cox turned to MD Anderson when local treatment failed to keep the cancer at bay. Here, a single dose of a novel cell therapy... nk cell therapy ut md anderson clinical trial follicular lymphoma car